John C. Baldwin M.D. is Director at QUEST DIAGNOSTICS INC (DGX). They have made 9 open-market trades across 1 company since 2011, most recently 2015-08-12.
CIK 0001285652
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DGX | SELL | 2015-08-12 | 2015-08-13 | $72.00 | $163K | -4.9% | +0.9% | +0.9% |
| DGX | SELL | 2014-07-29 | 2014-07-29 | $62.31 | $498K | -4.9% | +0.9% | +0.9% |
| DGX | SELL | 2013-11-05 | 2013-11-05 | $63.00 | $41K | -4.9% | +0.9% | +0.9% |
| DGX | SELL | 2013-10-31 | 2013-11-04 | $59.70 | $478K | -4.9% | +0.9% | +0.9% |
| DGX | SELL | 2013-05-14 | 2013-05-15 | $59.41 | $72K | -4.9% | +0.9% | +0.9% |
| DGX | SELL | 2012-08-08 | 2012-08-09 | $60.00 | $706K | -4.9% | +0.9% | +0.9% |
| DGX | SELL | 2012-05-01 | 2012-05-03 | $57.50 | $594K | -4.9% | +0.9% | +0.9% |
| DGX | SELL | 2012-01-26 | 2012-01-30 | $59.00 | $590K | -4.9% | +0.9% | +0.9% |
| DGX | SELL | 2011-02-09 | 2011-02-10 | $57.56 | $1.7M | -4.9% | +0.9% | +0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.